Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.779
AS - Asia 8.420
EU - Europa 8.143
SA - Sud America 1.079
AF - Africa 155
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 17
Totale 31.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.353
SG - Singapore 2.626
IT - Italia 2.289
CN - Cina 1.978
VN - Vietnam 1.692
DE - Germania 1.299
RU - Federazione Russa 1.077
HK - Hong Kong 944
BR - Brasile 865
SE - Svezia 812
IE - Irlanda 576
GB - Regno Unito 459
UA - Ucraina 362
CA - Canada 326
IN - India 289
FI - Finlandia 237
FR - Francia 189
ID - Indonesia 168
AT - Austria 149
PL - Polonia 148
KR - Corea 136
DK - Danimarca 116
JP - Giappone 95
NL - Olanda 95
AR - Argentina 86
ZA - Sudafrica 81
TR - Turchia 80
ES - Italia 76
BD - Bangladesh 68
MX - Messico 67
IR - Iran 55
BE - Belgio 54
IQ - Iraq 46
TW - Taiwan 43
PT - Portogallo 33
PK - Pakistan 31
RO - Romania 29
AU - Australia 27
EC - Ecuador 25
BG - Bulgaria 24
CO - Colombia 22
UZ - Uzbekistan 22
CH - Svizzera 21
GR - Grecia 21
CZ - Repubblica Ceca 20
LT - Lituania 20
VE - Venezuela 20
IL - Israele 19
CL - Cile 18
PY - Paraguay 18
SA - Arabia Saudita 16
JO - Giordania 15
KE - Kenya 15
MY - Malesia 15
EU - Europa 14
EG - Egitto 13
MA - Marocco 11
NP - Nepal 11
HU - Ungheria 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
UY - Uruguay 9
AZ - Azerbaigian 8
HN - Honduras 7
PH - Filippine 7
ET - Etiopia 6
KZ - Kazakistan 6
OM - Oman 6
AL - Albania 5
BB - Barbados 5
LB - Libano 5
MU - Mauritius 5
PA - Panama 5
TN - Tunisia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LY - Libia 2
NG - Nigeria 2
Totale 31.602
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.609
Ashburn 1.379
Hong Kong 917
Milan 914
Woodbridge 866
Frankfurt am Main 711
Fairfield 670
Chandler 632
Houston 578
Wilmington 567
Dublin 556
Ho Chi Minh City 507
Hanoi 400
Dearborn 370
Jacksonville 357
Beijing 350
Santa Clara 333
Dallas 331
Seattle 327
New York 307
Los Angeles 249
Cambridge 246
Hefei 194
Princeton 191
Nanjing 165
Jakarta 145
Shanghai 125
Vienna 123
Helsinki 109
São Paulo 99
Chicago 93
Buffalo 92
Toronto 89
The Dalles 88
Moscow 87
Guangzhou 85
Seoul 85
Kraków 74
Lawrence 72
Council Bluffs 70
Munich 70
San Diego 63
Altamura 62
Dong Ket 62
Tokyo 62
Warsaw 61
Ottawa 59
Lachine 58
Nanchang 55
Fremont 53
Denver 52
Rome 51
Brussels 50
London 46
Melzo 46
Haiphong 45
Nuremberg 44
Montreal 43
Wayne 43
Da Nang 42
Hangzhou 42
Johannesburg 41
Orem 40
Chennai 39
Ha Long 39
Kunming 39
Changsha 37
Pune 37
Boardman 36
Boston 36
Monza 35
Phoenix 35
Poplar 35
Stockholm 35
Andover 33
Shenyang 32
Brooklyn 31
Turku 31
Zhengzhou 31
Atlanta 30
Hebei 30
Biên Hòa 29
Hải Dương 29
San Jose 28
Bắc Ninh 27
Mumbai 27
Tianjin 27
Kent 26
Nürnberg 26
Thái Nguyên 26
Bologna 25
Grafing 25
Ankara 24
Can Tho 24
Genoa 24
Norwalk 24
Como 23
Ninh Bình 23
Columbus 22
Totale 20.220
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 646
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 590
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 534
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 524
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 477
A new approach for glyco-functionalization of collagen-based biomaterials 470
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 469
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 466
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 464
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 463
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 462
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 425
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 423
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 423
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 419
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 409
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 400
Phage-displayed peptides targeting specific tissues and organs 394
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 391
Nanomedicine for the treatment of Alzheimer's disease 383
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 374
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 367
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 363
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 349
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 348
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 347
Enhanced brain targeting of engineered solid lipid nanoparticles 341
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 338
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 334
Are the nanoparticles friends or foes when inhaled? 329
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 328
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 322
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 318
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 312
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 311
TrkA pathway activation induced by amyloid-beta (Abeta) 305
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 301
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 296
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 290
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 290
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 288
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 287
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 285
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 280
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 280
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 278
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 278
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 274
Effect of modified collagen on amyloid beta peptide aggregation 273
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 273
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 270
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 267
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 263
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 260
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 258
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 255
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 255
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 251
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 249
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 247
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 246
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 244
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 242
Enhanced brain targeting of engineered solid lipid nanoparticles 239
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 238
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 235
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 232
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 230
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 229
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 224
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 221
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 217
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 214
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 213
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 212
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 212
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 211
Nanotechnology for neurodegenerative disorders 208
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 208
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 205
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 205
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 205
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 204
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 204
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 203
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 201
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 197
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 195
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 195
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 189
Nanotechnology for neurodegenerative disorders 187
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 186
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 183
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 183
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 181
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 179
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 179
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 177
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 175
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 175
Totale 29.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.673 0 0 0 0 0 0 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/20268.908 2.445 987 1.230 1.650 1.851 744 1 0 0 0 0 0
Totale 32.547